Joseph Pitts actually said...

"FDA approved the first biosimilar in March 2015 and is convening an advisory committee next week to consider a second application."

"In 2009, this committee passed the Biologics Price Competition and Innovation Act (BPCIA) by a vote of 47 to 11."

"I was concerned that CMS finalized its Part B payment policy for biosimilars last year combining all biosimilars into one average sales price calculation and payment code."

"The Chair thanks the gentlelady. That concludes the questions that we have here. We have follow-up questions. We will submit those to you in writing. We ask that you please respond promptly."